Bal Pharma Ltd (BALPHARMA) — Board Meeting | 25 September 2026

Bal Pharma announced at its September 24, 2026 AGM the re-appointment of Ravindra Kumar Kothari as Director and his change in designation from Non-Executive to Whole-Time Executive Director effective October 1, 2026, while Virupakshaya Himesh was shifted from Whole-Time Director to Non-Executive Director effective the same date. The changes were recommended by the Nomination and Remuneration Committee on August 12, 2026 and approved by the Board on the same day, subject to member approval. The reconstitution of the Nomination and Remuneration Committee and Stakeholders’ Relationship Committee reflects these appointments, with Virupakshaya Himesh joining and Ravindra Kumar Kothari exiting both committees. The filing complies with SEBI LODR Regulation 30 and includes disclosures on shareholding and directorship eligibility.